Fluticasone propionate/formoterol fumarate: A review of its use in persistent asthma

Drugs

Volumn 73, Issue 2, 2013, Pages 195-206

  McKeage, Kate ^a  

^a Adis 41 ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; FLUTICASONE; FLUTICASONE PROPIONATE PLUS FORMOTEROL FUMARATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; PLACEBO; SALBUTAMOL;

ABNORMAL LABORATORY RESULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; ASTHMA; PROPIONATE PLUS FORMOTEROL FUMARATE; BRONCHITIS; BRONCHODILATATION; CORTICOSTEROID THERAPY; DISEASE CONTROL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHONIA; FORCED EXPIRATORY VOLUME; GENERAL CONDITION IMPROVEMENT; HUMAN; LONG TERM CARE; LUNG FUNCTION; MAXIMUM PLASMA CONCENTRATION; MONOTHERAPY; MORNING DOSAGE; PHARYNGITIS; RECOMMENDED DRUG DOSE; RHINOPHARYNGITIS; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VIRUS INFECTION;

ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; HUMANS; METERED DOSE INHALERS;

EID: 84877026547     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.1007/s40265-013-0016-4     Document Type: Article

References (25)

1. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. 2008, revised January 2012. http://www.sign.ac.uk/pdf/sign101.pdf. Accessed 7 Jan 2013.
2. National Health Service Clinical Knowledge Summaries. How common is asthma? 2006. http://www.cks.nhs.uk/asthma/background-information/prevalence. Accessed 21 Dec 2012.
3. 2-agonists and corticosteroids. Eur Respir J. 2002;19(1):182-91.
4. Medicines Compendium UK. Flutiform pressurised inhalation, suspension: summary of product characteristics 2012. http://www.medicines.org.uk/emc/ medicine/26954. Accessed 7 Jan 2013.
5. Holliday SM, Faulds D, Sorkin EM. Inhaled fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma. Drugs. 1994;47(2):318-31.
6. Bartow RA, Brogden RN. Formoterol: an update of its pharmacological properties and therapeutic efficacy in the management of asthma. Drugs. 1998;55(2):303-22.
7. Hochhaus G, Kaiser K. Comparing the safety and efficacy of fluticasone/formoterol combination therapy in a single inhaler at low and medium doses, with fluticasone and formoterol concurrently or alone, in asthma patients [abstract no. 1549]. Allergy. 2011;66(Suppl. 94):585.
8. Priestley A, Woodward J, McIver T, et al. Effect of high dose inhaled fluticasone/formoterol combination therapy compared with its separate components on the hypothalamo-pituitary-adrenal (HPA) axis function [abstract no. 1553]. Allergy. 2011;66(Suppl. 94):586.
9. Tamm M, Kaiser K, Grothe B, et al. Effects on adrenal function of a new combination of fluticasone propionate/formoterol fumarate administered to asthmatic patients and healthy subjects [abstract no. P4010]. 21st Annual Congress of the European Respiratory Society, Amsterdam; 24-28 Sep 2011.
10. Baljinder J, Howald M, Fischer M, et al. Comparison of the fine particle fraction of fluticasone propionate/formoterol fumarate combination with other combination products [abstract no. P1158]. European Respiratory Society Annual Congress, Vienna; 1-5 Sep, 2012.
11. Hochhaus G, Kaiser K. Pharmacokinetics of fluticasone/formoterol combination therapy in a single inhaler compared with fluticasone and formoterol concurrently or alone in healthy subjects: results of two open label studies [abstract no. 1550]. Allergy. 2011;66:585.
12. Corren J, Mansfield LE, Pertseva T, et al. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma. Resp Med. 2013;107(2):180-95.
13. Nathan RA, D'Urzo A, Blazhko V, et al. Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial. BMC Pulm Med. 2012;18(12):67.
14. Pearlman DS, Laforce C, Kaiser K. Fluticasone propionate/formoterol fumarate combination therapy has superior efficacy to both fluticasone and formoterol alone [abstract no. P3990]. 21st Annual Congress of the European Respiratory Society, Amsterdam; 24-28 Sep 2011.
15. Pertseva T, Dissanayake S, Kaiser K. Efficacy and safety of fluticasone/formoterol compared to fluticasone alone in patients with asthma [abstract no. 2191]. European Respiratory Society Annual Congress, Vienna; 1-5 Sep 2012.
16. Bodzenta-Lukaszyk A, Pulka G, Dymek A, et al. Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. Respir Med. 2011;105(5):674-82.
17. Bodzenta-Lukaszyk A, van Noord JA, Schroder-Babo WG, et al. Fluticasone propionate/formoterol fumarate combination therapy has comparable efficacy to its individual components administered concurrently [abstract no. P4007]. 21st Annual Congress of the European Respiratory Society, Amsterdam; 24-28 Sep 2011.
18. Bodzenta-Lukaszyk A, Dymek A, McAulay K, et al. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. BMC Pulm Med. 2011;11:28.
19. Bodzenta-Lukaszyk A, Buhl R, Balint B, et al. Fluticasone/formoterol combination therapy versus budesonide/ formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety. J Asthma. 2012;. doi: 10.3109/02770903.2012.719253.
20. Mansur A, Kaiser K. Long-term safety study and efficacy of futicasone/formoterol combination therapy in asthma. J Aerosol Med Pulm Drug Deliv. 2012. doi: 10.1089/jamp.2012.0977.
21. Price D, Papi A, Kaiser K, et al. Patients with asthma show greater improvements in lung function after combination therapy with fluticasone propionate/formoterol fumarate than with its individual components administered alone [abstract no. 277]. 6th International Primary Care and Respiratory Group World Conference, Edinburgh; 25-28 Apr 2012.
22. Dissanayake S, Lomax M, Kaiser T, et al. Asthma exacerbation with fluticasone propionate/formoterol fumarate combination therapy versus its individual components [abstract no. P2096]. European Respiatory Society Annual Congress, Vienna; 1-5 Sep 2012.
23. Price D, Papi A, Kaiser K, et al. Fluticasone propionate/formoterol fumarate combination therapy is equally effective and well-tolerated when administered with or without a spacer device to patients with asthma [abstract no. P3986]. 21st Annual Congress of the European Respiratory Society, Amsterdam; 24-28 Sep 2011.
24. Aalbers R, Brusselle G, McIver T, et al. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study. Adv Therapy. 2012;28(11):958-69.
25. Harding G, Leidy NK, Meddis D, et al. Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel. Curr Med Res Opin. 2009;25(6):1563-71.